Cernak, M. and Nogova, L. (2016). Current antiangiogenic agents in oncology and ophthalmology. Neoplasma, 63 (1). S. 10 - 18. BRATISLAVA: AEPRESS SRO. ISSN 1338-4317
Full text not available from this repository.Abstract
Antiangiogenic drugs are approved for many cancer types for longer than a decade. Furthermore, several antiangiogenic agents are approved for local application in ophthalmology for treatment of macular degeneration, venous retinal occlusion and diabetic retinopathy. Knowing that antiangiogenic agents are active in ocular system, we reviewed the current literature, whether antiangiogenic drugs may cause ocular side effects in cancer patients by systemic application. Furthermore, we searched in published papers, if systemic application of antiangiogenic agents in cancer patients may simultaneously treat their ocular disorders, if they have such. Finally, we emphasized cooperation between an oncologist and ophthalmologist when treating patients with antiangiogenic drugs.
Item Type: | Journal Article | ||||||||||||
Creators: |
|
||||||||||||
URN: | urn:nbn:de:hbz:38-293157 | ||||||||||||
DOI: | 10.4149/neo_2016_001 | ||||||||||||
Journal or Publication Title: | Neoplasma | ||||||||||||
Volume: | 63 | ||||||||||||
Number: | 1 | ||||||||||||
Page Range: | S. 10 - 18 | ||||||||||||
Date: | 2016 | ||||||||||||
Publisher: | AEPRESS SRO | ||||||||||||
Place of Publication: | BRATISLAVA | ||||||||||||
ISSN: | 1338-4317 | ||||||||||||
Language: | English | ||||||||||||
Faculty: | Unspecified | ||||||||||||
Divisions: | Unspecified | ||||||||||||
Subjects: | no entry | ||||||||||||
Uncontrolled Keywords: |
|
||||||||||||
Refereed: | Yes | ||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/29315 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
View Item |